City Therapeutics
Sebastian Trousil is a seasoned professional in the biotechnology and investment sectors, currently serving as Co-Founder and Chief Operating Officer at City Therapeutics and as Principal of New Ventures at RTW Investments, LP. Trousil previously held key roles at Yarrow Biotechnology as a Founding Team Member and Chief Operating Officer, and at Flagship Pioneering, where Trousil progressed from Associate to Senior Associate. Additionally, Sebastian Trousil co-founded Harbinger Health, further demonstrating a strong entrepreneurial background in innovative health solutions.
This person is not in any teams
This person is not in any offices
City Therapeutics
Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to improve and expand the reach of RNAi-based medicines. City’s mission is to build the leading next-generation RNAi therapeutics company, unlocking RNAi’s transformative potential to help patients with a wide range of diseases.